3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Hepatocellular
9
Small Cell Lung Carcinoma
5
Carcinoma, Transitional Cell
5
Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Breast Neoplasms
2
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Sarcopenia
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
tremelimumab
1
durvalumab
1
atezolizumab
1
Therapeutics
1
Immunotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Unresectable Hepatocellular Carcinoma
×
atezolizumab
×
Clear all
NCT06117891
2026-05-12
REFINE-IO
Bayer
Active not recruiting
300 enrolled